How much revenue does C-Rad AB (publ) make?

C-Rad AB (publ) reported 469.00 million SEK in revenue for fiscal year 2024, up 10.5% from 424.62 million SEK in fiscal year 2023. In Q2 2025 revenue was 105.20 million SEK.

What companies are similar to C-Rad AB (publ)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Dynavox Group AB (publ) (DYVOX.ST), Paxman AB (publ) (PAX.ST), Episurf Medical AB (publ) (EPIS-B.ST), Bactiguard Holding AB (publ) (BACTI-B.ST).

C-Rad AB (publ) (CRAD-B.ST) Stock

About C-Rad AB (publ)

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a soluti...

At a glance

C-Rad AB (publ) reported revenue of 469.00 million SEK for fiscal year 2024, up 10.5% from fiscal year 2023, and net income of 56.45 million SEK. In Q2 2025 (the quarter ended June 30, 2025) revenue was 105.20 million SEK, down 18.7% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2024.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.